Literature DB >> 13862111

Anticipation of chloroquine retinopathy.

G B ARDEN, A FRIEDMANN, H KOLB.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/toxicology; RETINA/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13862111     DOI: 10.1016/s0140-6736(62)92200-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.

Authors:  G D KERSLEY
Journal:  Proc R Soc Med       Date:  1964-08

2.  ELECTRODIAGNOSTIC TESTS IN EYE DISEASE.

Authors:  J BEHRMAN
Journal:  Postgrad Med J       Date:  1964-12       Impact factor: 2.401

3.  Eye changes with chloroquine.

Authors: 
Journal:  Br Med J       Date:  1966-04-02

4.  Ocular Complications of Treatment with Chloroquine and Related Antimalarial Drugs.

Authors: 
Journal:  Can Med Assoc J       Date:  1963-03-09       Impact factor: 8.262

5.  Angioid streaks and elastorrhexis.

Authors:  S P Percival
Journal:  Br J Ophthalmol       Date:  1968-04       Impact factor: 4.638

6.  Electro-oculogram findings in patients treated with antimalarial drugs.

Authors:  H Kolb
Journal:  Br J Ophthalmol       Date:  1965-11       Impact factor: 4.638

7.  EOG as a monitor of desferrioxamine retinal toxicity.

Authors:  Rudy R Hidajat; Jan L McLay; David H Goode; Ruth L Spearing
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

8.  Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.

Authors:  G B Arden; H Kolb
Journal:  Br Med J       Date:  1966-01-29

Review 9.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

10.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.